18:04 , Jul 10, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Prostate cancer Cell culture studies identified a compound that recruits androgen receptor to IAP for proteasomal degradation that could help treat prostate cancer. The compound consisted of an androgen receptor ligand and a peptidomimetic...
07:00 , Aug 21, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Androgen receptor (AR); prostate-specific antigen (KLK3; PSA) In vitro studies have identified indole carboxamide-based AR inhibitors that could help treat prostate cancer. In...
07:00 , Aug 28, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Androgen receptor (AR) Studies in cell culture and in mice suggest that targeting AR in the tumor epithelium...
08:00 , Mar 11, 2002 |  BioCentury  |  Strategy

Schering looks to acquire elsewhere

Schering looks to acquire elsewhere...